Financing, Equity Capital Markets

Fate Therapeutics, Inc.

09/18
|
$143.8 Million
Piper Sandler served as bookrunner for Fate Therapeutics, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sector
Healthcare
Sub-Sector
Biopharma

Related Transactions

All Transactions
$110.0 Million
3
Nektar Therapeutics
ATM Program Common Stock
Lead Sales Agent
$40.0 Million
r
Colony Bank
ATM Program Common Stock
Sole Sales Agent
$50.0 Million
jk
Midwest BankCentre
Subordinated Notes
Lead Placement Agent
d
e
Phoenix Physical Therapy
Sr. Secured Term Loan
Delayed Draw Term Loan & Revolver
Sole Placement Agent
$25.0 Million
w
Orange County Bancorp
Subordinated Notes
Sole Placement Agent
$135.0 Million
r
t
APT Healthcare
Sr. Secured Term Loan
Delayed Draw Term Loan & Revolver
Sole Placement Agent
$25.0 Million
k
Mascoma Mutual Financial Services
Subordinated Notes
Sole Placement Agent
$59.0 Million
c
ncgCARE
Sr. Secured Term Loan
Delayed Draw Term Loan & Revolver
Sole Placement Agent
$50.0 Million
u
Minnwest Corporation
Subordinated Notes
Sole Placement Agent
$18.0 Million
parkside
Parkside Financial Bank & Trust
Subordinated Notes
Sole Placement Agent
$40.0 Million
uscb
USCB Financial Holdings
Subordinated Notes
Sole Placement Agent
$200.0 Million
the bancorp
The Bancorp
Senior Notes
Joint Bookrunner
$75.0 Million
byline
Byline Bancorp
Subordinated Notes
Sole Placement Agent
$200.0 Million
w
EverBank Financial Corp
Subordinated Notes
Sole Bookrunner
j
Smithstown Light Engineering
Sr. Secured Term Loan & Revolver
Sole Placement Agent
$57.0 Million
ramaco
Ramaco Resources
Senior Notes Offering
Active Bookrunner

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.